Results 261 to 270 of about 6,418,846 (364)

Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarker

Molecular Oncology, EarlyView.
Urinary LGALS3BP is elevated in bladder cancer patients compared to healthy controls as detected by the 1959 antibody–based ELISA. The antibody shows enhanced reactivity to the high‐mannose glycosylated variant secreted by cancer cells treated with kifunensine (KIF).
Asia Pece, Giulio Lovato, Ilaria Cela, Arianna Mercatelli, Benedetta Ferro, Jussi Nikkola, Sara Pagotto, Tommaso Grottola, Vincenzo De Laurenzi, Rossella Cicchetti, Antonio Marchetti, Luigi Schips, Rossano Lattanzio, Stefano Iacobelli, Emily Capone, Peter Black, Mads Daugaard, Michele Marchioni, Gianluca Sala   +18 more
wiley   +1 more source

Pubertas Precox in A Six-Year-Old Boy Produced by a Tumor of the Testis, Probably of Interstitial Cell Origin

, 1942
AUGUST A. WERNER, Harry Spector, Alvin E. Vitt, Wallace L. Ross, Winston A. Anderson   +4 more
openalex   +1 more source

Emerging role of cancer-associated fibroblasts in the premetastatic niche. [PDF]

Mol Cancer
Yang S, Guo Y, Jia J, Cui W, Zhang X, Wang Y, Xie Z, Fang Y, Ding X, Chang L, Liu Y.   +10 more
europepmc   +1 more source

Survivin and Aurora Kinase A control cell fate decisions during mitosis

Molecular Oncology, EarlyView.
Aurora A interacts with survivin during mitosis and regulates its centromeric role. Loss of Aurora A activity mislocalises survivin, the CPC and BubR1, leading to disruption of the spindle checkpoint and triggering premature mitotic exit, which we refer to as ‘mitotic slippage’.
Hana Abdelkabir, Shalitha Wickrama Arachchige, Sally P. Wheatley   +2 more
wiley   +1 more source

Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers

Cell, 2013
Jakob Lovén, Heather A. Hoke, Charles Y. Lin, Ashley Lau, David A. Orlando, C. Vakoc, J. Bradner, Tong Ihn Lee, R. Young   +8 more
semanticscholar   +1 more source

Tumor and immune cell distribution in the tumor core and outer part of glioblastoma, IDH wildtype. [PDF]

J Neurooncol
Pedersen V, Knudsen AM, Michaelsen SR, Dahlrot RH, Kristensen BW.   +4 more
europepmc   +1 more source

Imperial strategy of cancer cells through mitochondrial transfer

Molecular Oncology, EarlyView.
Cangkrama et al. demonstrated that cancer cells donate their mitochondria to fibroblasts through mitochondrial transfer, reprogramming them into ‘MitoCAF’. Likewise, our group has identified mitochondrial transfer from cancer cells to tumor infiltrating lymphocytes, resulting in mitochondrial ‘hijack’ and impaired antitumor immunity.
Takamasa Ishino, Yosuke Togashi
wiley   +1 more source

Intein‐based modular chimeric antigen receptor platform for specific CD19/CD20 co‐targeting

Molecular Oncology, EarlyView.
CARtein is a modular CAR platform that uses split inteins to splice antigen‐recognition modules onto a universal signaling backbone, enabling precise, scarless assembly without re‐engineering signaling domains. Deployed here against CD19 and CD20 in B‐cell malignancies, the design supports flexible multi‐antigen targeting to boost T‐cell activation and
Pablo Gonzalez‐Garcia, Noelia Moares, Wenjie Yi‐He, Rosa Luna‐Espejo, Ricardo Fernandez‐Cisnal, Javier Ocaña‐Cuesta, Juan P. Muñoz‐Miranda, Antonio Gabucio, Cecilia M. Fernandez‐Ponce, Francisco Garcia‐Cozar   +9 more
wiley   +1 more source

CD68- and CD163-positive tumor-associated macrophages in renal clear cell carcinoma. [PDF]

Sci Rep
Yang Y, Sun D, Ma X, Wang T, Wu J.
europepmc   +1 more source